According to Biolase 's latest financial reports the company's current EPS (TTM) is -ยฃ199.24. In 2022 the company made an earnings per share (EPS) of -ยฃ309.08 a decrease over its 2021 EPS that were of -ยฃ201.16.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -ยฃ225.90 | -26.91% |
2022 | -ยฃ309.08 | 53.65% |
2021 | -ยฃ201.16 | -81.87% |
2020 | -ยฃ1,109 | -25.32% |
2019 | -ยฃ1,485 | -24.76% |
2018 | -ยฃ1,974 | -26.06% |
2017 | -ยฃ2,670 | 4.33% |
2016 | -ยฃ2,559 | -14.71% |
2015 | -ยฃ3,000 | -26.09% |
2014 | -ยฃ4,059 | 35.41% |
2013 | -ยฃ2,998 | 244.31% |
2012 | -ยฃ870.64 | -38.05% |
2011 | -ยฃ1,405 | -64.8% |
2010 | -ยฃ3,993 | 347.66% |
2009 | -ยฃ891.87 | -71.05% |
2008 | -ยฃ3,081 | 22.58% |
2007 | -ยฃ2,513 | 55% |
2006 | -ยฃ1,622 | -74.03% |
2005 | -ยฃ6,243 | -22.22% |
2004 | -ยฃ8,027 | -208.79% |
2003 | ยฃ7,378 | 1720% |
2002 | ยฃ405.39 | -171.43% |
2001 | -ยฃ567.55 | -65% |
2000 | -ยฃ1,622 | -28.57% |
1999 | -ยฃ2,270 | -56.92% |
1998 | -ยฃ5,270 | 209.52% |
1997 | -ยฃ1,703 | 5% |
1996 | -ยฃ1,622 |